These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM. Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253 [Abstract] [Full Text] [Related]
6. Study of Risk Factors Associated With Recurrent Primary Sclerosing Cholangitis After Liver Transplantation in Shiraz >From 2011 to 2021. Taghavi SA, Safarpour AR, Ghahramani S, Moghadam SM, Shahramian I, Sivandzadeh GR, Nikeghbalian S, Tahani M, Saeian S, Malek-Hosseini SA. Exp Clin Transplant; 2024 Jul; 22(7):531-539. PubMed ID: 39223811 [Abstract] [Full Text] [Related]
7. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. Lai YH, Duan WD, Yu Q, Ye S, Xiao NJ, Zhang DX, Huang ZQ, Yang ZY, Dong JH. World J Gastroenterol; 2015 May 28; 21(20):6296-303. PubMed ID: 26034365 [Abstract] [Full Text] [Related]
8. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India. Jadaun SS, Mehtani R, Hasnain A, Bhatia S, Moond V, Kumar M, Kuhad V, Singh S, Agarwal S, Gupta S, Saigal S. Hepatol Int; 2023 Apr 28; 17(2):499-506. PubMed ID: 36376772 [Abstract] [Full Text] [Related]
9. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients. Venkat VL, Ranganathan S, Mazariegos GV, Sun Q, Sindhi R. Liver Transpl; 2014 Jun 28; 20(6):679-86. PubMed ID: 24634351 [Abstract] [Full Text] [Related]
11. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis. Martin EF, Levy C. Semin Liver Dis; 2017 Nov 28; 37(4):305-313. PubMed ID: 29272893 [Abstract] [Full Text] [Related]
12. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. AJR Am J Roentgenol; 1993 Aug 28; 161(2):297-300. PubMed ID: 8333366 [Abstract] [Full Text] [Related]
14. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience. Emek E, Serin A, Sahin T, Yazici P, Yuzer Y, Tokat Y, Bozkurt B. Transplant Proc; 2019 Sep 28; 51(7):2439-2441. PubMed ID: 31405746 [Abstract] [Full Text] [Related]
15. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT. Liver Transpl; 2003 Jul 28; 9(7):727-32. PubMed ID: 12827560 [Abstract] [Full Text] [Related]
16. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Duclos-Vallee JC, Sebagh M. Liver Transpl; 2009 Nov 28; 15 Suppl 2():S25-34. PubMed ID: 19876939 [Abstract] [Full Text] [Related]
18. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. Linder S, Söderlund C. Hepatogastroenterology; 2001 Nov 28; 48(38):387-92. PubMed ID: 11379315 [Abstract] [Full Text] [Related]